» Articles » PMID: 38543693

HPV and Cervical Cancer: Molecular and Immunological Aspects, Epidemiology and Effect of Vaccination in Latin American Women

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2024 Mar 28
PMID 38543693
Authors
Affiliations
Soon will be listed here.
Abstract

Cervical cancer is primarily caused by Human Papillomavirus (HPV) infection and remains a significant public health concern, particularly in Latin American regions. This comprehensive narrative review addresses the relationship between Human Papillomavirus (HPV) and cervical cancer, focusing on Latin American women. It explores molecular and immunological aspects of HPV infection, its role in cervical cancer development, and the epidemiology in this region, highlighting the prevalence and diversity of HPV genotypes. The impact of vaccination initiatives on cervical cancer rates in Latin America is critically evaluated. The advent of HPV vaccines has presented a significant tool in combating the burden of this malignancy, with notable successes observed in various countries, the latter due to their impact on immune responses. The review synthesizes current knowledge, emphasizes the importance of continued research and strategies for cervical cancer prevention, and underscores the need for ongoing efforts in this field.

Citing Articles

Association between cardiovascular health and human papillomavirus infection: analysis from NHANES 2005-2016.

Li M, Song M Front Public Health. 2024; 12:1501409.

PMID: 39651469 PMC: 11621051. DOI: 10.3389/fpubh.2024.1501409.


Labeled-free quantitative proteomic analysis of cervical squamous cell carcinoma identifies potential protein biomarkers.

Bai H, Zheng H PeerJ. 2024; 12:e17444.

PMID: 38952985 PMC: 11216203. DOI: 10.7717/peerj.17444.

References
1.
Schiller J, Lowy D . Explanations for the high potency of HPV prophylactic vaccines. Vaccine. 2018; 36(32 Pt A):4768-4773. PMC: 6035892. DOI: 10.1016/j.vaccine.2017.12.079. View

2.
Bahramabadi R, Dabiri S, Iranpour M, Arababadi M . TLR4: An Important Molecule Participating in Either Anti-Human Papillomavirus Immune Responses or Development of Its Related Cancers. Viral Immunol. 2019; 32(10):417-423. DOI: 10.1089/vim.2019.0061. View

3.
Torres-Poveda K, Bahena-Roman M, Madrid-Gonzalez C, Burguete-Garcia A, Bermudez-Morales V, Peralta-Zaragoza O . Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia. World J Clin Oncol. 2014; 5(4):753-63. PMC: 4129538. DOI: 10.5306/wjco.v5.i4.753. View

4.
Sechi I, Muresu N, Puci M, Saderi L, Del Rio A, Cossu A . Preliminary Results of Feasibility and Acceptability of Self-Collection for Cervical Screening in Italian Women. Pathogens. 2023; 12(9). PMC: 10535381. DOI: 10.3390/pathogens12091169. View

5.
Sichero L, Picconi M, Villa L . The contribution of Latin American research to HPV epidemiology and natural history knowledge. Braz J Med Biol Res. 2020; 53(2):e9560. PMC: 6993359. DOI: 10.1590/1414-431X20199560. View